Scientists Map Gut Drainage System to Reveal Hidden Health Biomarkers
New research identifies unique molecular signatures in gut lymph and blood that could transform digestive health monitoring.
20 articles
New research identifies unique molecular signatures in gut lymph and blood that could transform digestive health monitoring.
Stanford researchers create comprehensive database showing how maternal diet, microbiome, and medications affect fetal development.
Just 48 hours of eating mostly oatmeal dramatically reduced LDL cholesterol in people with metabolic syndrome, with benefits lasting weeks.
Dr. Jamnadas reveals how popular breakfast choices create energy crashes and behavioral issues in children.
Pediatrician shares fiber-rich, probiotic breakfast ideas that can be prepped in minutes to boost children's focus and health.
Scientists uncover how faulty glycogen-priming proteins cause progressive cardiomyopathy, pointing toward gene therapy and autophagy as future treatments.
Dr. Jamnadas reveals how popular lunch items spike insulin, cause fatty liver, and impair cognitive function.
Dr. Jamnadas explains how emulsifiers in bread and ice cream disrupt gut health and why simple ingredient lists matter for longevity.
A new framework combining rapid point-of-care fibrinogen testing, viscoelastic assays, and lab tests could eliminate preventable postpartum deaths.
Dr. Jamnadas explains why fiber diversity from colorful whole foods feeds beneficial gut bacteria that produce essential micronutrients.
A simple cooking hack transforms regular rice into gut-friendly resistant starch that feeds beneficial bacteria instead of spiking blood sugar.
A pill-form GLP-1 receptor agonist significantly reduced multiple cardiovascular risk markers in both T2D and obesity patients over 26โ36 weeks.
Dr. Pradip Jamnadas and pediatrician Dr. Manisha Taylor share four nutrient-dense lunch recipes ready in 5 minutes or less.
New analysis reveals oral semaglutide significantly reduces cardiovascular risk factors beyond blood sugar control in type 2 diabetes.
Dr. Jamnadas explains how sugar and alcohol cause identical fatty liver damage, setting up children for diabetes by age 35-40.
New oral drug MK-0616 matches injectable PCSK9 inhibitors for lowering LDL cholesterol while offering patient-friendly pill form.
An 80-week Amgen-sponsored Phase 3 trial evaluated evolocumab's safety and efficacy in pediatric patients aged 10โ17 with inherited high LDL cholesterol.
New research shows limiting sugar from pregnancy through age 2 dramatically reduces cardiovascular disease risk in adulthood.
12-week vitamin D treatment reduced IBD inflammation by promoting immune tolerance to beneficial gut bacteria through multiple pathways.
Dr. Jamnadas reveals how dietary choices directly impact gut bacteria diversity and overall health optimization through practical nutrition strategies.